Semaglutide and Insulin 287 Pharmacokinetics: Alone vs. Combined in Type 2 Diabetes
A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
Abstract
A randomized crossover study will investigate the pharmacokinetics of semaglutide and insulin 287 when administered alone or in combination in Type 2 Diabetes patients.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
